|
While a great deal of attention has been focused on the treatment and prevention of major diseases such as malaria and other conditions using key green tea extracts such as Epigallocatechin gallate (EGCG)
|
|
Read more...
|
|
This undiscovered Bakken play could be hugely profitable next year and double from current prices.
|
|
Read more...
|
|
On the heels of the latest Barron's cover story, marijuana use is a topic that will continue to gain fans and ultimately approval.
|
|
Read more...
|
|
While the benefits of FIT OPEB to municipalities have taken center stage, the FIT plan for wealthy and uber-wealthy individuals could be a meaningful profit center for INSCOR
|
|
Read more...
|
|
The Company is successful in developing a treatment or preventive vehicle for malaria, it could be a very profitable game-changer for the Company given its South Africa plantation and botanical-based therapeutic and go a long way toward cost-effectively eliminating one of the world’s most severe health issues.
|
|
Read more...
|
|
Nuvilex Inc. (OTCQB – NVLX) could be viewed as a two-headed oncology treatment entity, rather than a firm with a single, proven oncology indication in its arsenal.
|
|
Read more...
|
|
Plandai Biotechnology develops rich highly bioavailable extracts to treat diseases and medical conditions
|
|
Read more...
|
|
There are 3 reasons why our price target had to be increased by 40% and could be raised even higher in the coming months. 1.New value for breast cancer indication 2.Nanomedicine getting major dollars 3.Firm gearing up for future trials
|
|
Read more...
|
